These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33753174)
41. The PINK1-Parkin axis: An Overview. Tanaka K Neurosci Res; 2020 Oct; 159():9-15. PubMed ID: 31982458 [TBL] [Abstract][Full Text] [Related]
42. Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond. Bingol B; Sheng M Free Radic Biol Med; 2016 Nov; 100():210-222. PubMed ID: 27094585 [TBL] [Abstract][Full Text] [Related]
43. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin. Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667 [TBL] [Abstract][Full Text] [Related]
44. Structural basis for feedforward control in the PINK1/Parkin pathway. Sauvé V; Sung G; MacDougall EJ; Kozlov G; Saran A; Fakih R; Fon EA; Gehring K EMBO J; 2022 Jun; 41(12):e109460. PubMed ID: 35491809 [TBL] [Abstract][Full Text] [Related]
45. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. Yan C; Gong L; Chen L; Xu M; Abou-Hamdan H; Tang M; Désaubry L; Song Z Autophagy; 2020 Mar; 16(3):419-434. PubMed ID: 31177901 [TBL] [Abstract][Full Text] [Related]
47. Mitophagy: the latest problem for Parkinson's disease. Vives-Bauza C; Przedborski S Trends Mol Med; 2011 Mar; 17(3):158-65. PubMed ID: 21146459 [TBL] [Abstract][Full Text] [Related]
48. Regulation by mitophagy. Hattori N; Saiki S; Imai Y Int J Biochem Cell Biol; 2014 Aug; 53():147-50. PubMed ID: 24842103 [TBL] [Abstract][Full Text] [Related]
49. Uncovering the roles of PINK1 and parkin in mitophagy. Matsuda N; Tanaka K Autophagy; 2010 Oct; 6(7):952-4. PubMed ID: 20724841 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond. Bayne AN; Trempe JF Cell Mol Life Sci; 2019 Dec; 76(23):4589-4611. PubMed ID: 31254044 [TBL] [Abstract][Full Text] [Related]
54. Structure of the second phosphoubiquitin-binding site in parkin. Fakih R; Sauvé V; Gehring K J Biol Chem; 2022 Jul; 298(7):102114. PubMed ID: 35690145 [TBL] [Abstract][Full Text] [Related]
55. The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity. Ando M; Fiesel FC; Hudec R; Caulfield TR; Ogaki K; Górka-Skoczylas P; Koziorowski D; Friedman A; Chen L; Dawson VL; Dawson TM; Bu G; Ross OA; Wszolek ZK; Springer W Mol Neurodegener; 2017 Apr; 12(1):32. PubMed ID: 28438176 [TBL] [Abstract][Full Text] [Related]
56. USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy. Niu K; Fang H; Chen Z; Zhu Y; Tan Q; Wei D; Li Y; Balajee AS; Zhao Y Autophagy; 2020 Apr; 16(4):724-734. PubMed ID: 31432739 [TBL] [Abstract][Full Text] [Related]
57. Parkin: a multifaceted ubiquitin ligase. Moore DJ Biochem Soc Trans; 2006 Nov; 34(Pt 5):749-53. PubMed ID: 17052189 [TBL] [Abstract][Full Text] [Related]